Anticonceptivo oral de Bayer Natazia asociado con efectos adversos graves

 

Washington, DC: Natazia (valerato de estradiol valerato de estradiol y dienogest), un anticonceptivo de cuarta generación oral hecho por el gigante farmacéutico Bayer HealthCare Pharmaceuticals, Inc, fue aprobado por la FDA el 15 de marzo de 2012, para el tratamiento del sangrado menstrual abundante que no es causado por condiciones diagnosticadas del útero. Anticonceptivo oral de Bayer Natazia asociado con efectos adversos graves

US Food, Drug and Cosmetic Act

The Federal Government controls drugs in interstate commerce through the captioned act. The basic purpose of the act is to protect public health by making sure that drugs are pure, safe and effective when used as intended. The act also protects consumers from dangerous drugs, misleading labels, and fraud. This exercise of federal authority does not affect the power each state to control drugs within its own territories provided its laws are consistent with the federal law.